Response to: "Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?" - Sallam DE; Elhenawy YIM; Ahmed AMA; Taha SIA; Elsayed EM (Pediatric nephrology (Berlin, Germany), 2025)